Literature DB >> 18310451

Obestatin inhibits vasopressin secretion: evidence for a physiological action in the control of fluid homeostasis.

Willis K Samson1, Gina L C Yosten, Jaw-Kang Chang, Alastair V Ferguson, Meghan M White.   

Abstract

Obestatin, a product of post-translational processing of the ghrelin prohormone, has been reported to act in the brain to inhibit thirst. We extended our initial studies on water drinking by examining the effects of obestatin on hypovolemia-induced water and saline drinking and vasopressin release in male rats. Intracerebroventricular administration of obestatin significantly inhibited water, but not saline (0.3 M NaCl) drinking in response to a hypovolemic challenge. Obestatin also inhibited, in a dose-related fashion, dehydration-induced vasopressin secretion without affecting plasma oxytocin levels. Vasopressin release induced by central angiotensin II administration was attenuated significantly by prior administration of obestatin. Finally, central administration of an antiserum specific to obestatin resulted in an exaggerated basal vasopressin release and an increased vasopressin response to overnight water deprivation. Antiserum treatment also resulted in significantly increased ad libitum water drinking and drinking in response to dehydration. We conclude that this product of post-translational processing of the ghrelin prohormone may be an important contributor to the physiologic regulation of fluid and electrolyte homeostasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18310451     DOI: 10.1677/JOE-07-0364

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  11 in total

1.  Effects of single intranasal administration of obestatin fragments on the body weight and feeding and drinking behaviors.

Authors:  E E Khirazova; M V Maslova; E S Motorykina; D A Frid; A V Graf; A S Maklakova; N A Sokolova; A A Kamenskii
Journal:  Dokl Biol Sci       Date:  2014-01-03

Review 2.  Biological effects of obestatin.

Authors:  Jiang-Bo Li; Akihiro Asakawa; Kaichun Cheng; Yingxiao Li; Huhe Chaolu; Minglun Tsai; Akio Inui
Journal:  Endocrine       Date:  2011-03-20       Impact factor: 3.633

3.  Repeated administration of angiotensin II reduces its dipsogenic effect without affecting saline intake.

Authors:  Peter J Vento; Derek Daniels
Journal:  Exp Physiol       Date:  2010-03-12       Impact factor: 2.969

4.  The effect of ghrelin on water intake during dipsogenic conditions.

Authors:  Elizabeth G Mietlicki; Erica L Nowak; Derek Daniels
Journal:  Physiol Behav       Date:  2008-08-11

5.  Adropin acts in brain to inhibit water drinking: potential interaction with the orphan G protein-coupled receptor, GPR19.

Authors:  Lauren M Stein; Gina L C Yosten; Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-01-06       Impact factor: 3.619

6.  Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39.

Authors:  Jian V Zhang; Holger Jahr; Chin-Wei Luo; Cynthia Klein; Kristof Van Kolen; Luc Ver Donck; Ananya De; Esther Baart; Jing Li; Dieder Moechars; Aaron J W Hsueh
Journal:  Mol Endocrinol       Date:  2008-03-12

Review 7.  The phoenixins: From discovery of the hormone to identification of the receptor and potential physiologic actions.

Authors:  Lauren M Stein; Christopher J Haddock; Willis K Samson; Grant R Kolar; Gina L C Yosten
Journal:  Peptides       Date:  2018-06-19       Impact factor: 3.750

8.  Maternal-infant separation impedes changes in feeding behavior during estrous cycle of rats.

Authors:  Shinichi Iwasaki; Koki Inoue
Journal:  Exp Anim       Date:  2015-06-29

9.  Emerging markers of cachexia predict survival in cancer patients.

Authors:  Patrizia Mondello; Antonio Lacquaniti; Stefania Mondello; Davide Bolignano; Vincenzo Pitini; Carmela Aloisi; Michele Buemi
Journal:  BMC Cancer       Date:  2014-11-16       Impact factor: 4.430

Review 10.  Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Authors:  Elaine Cowan; Kerry J Burch; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2016-05-27       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.